Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMBQRGV)

Drug Name
NT-501 CNTF Drug Info
Indication
Disease Entry ICD 11 Status REF
Ovarian cancer 2C73 Phase 1/2 [1]
Cross-matching ID
TTD Drug ID
DMBQRGV

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Ciliary neurotrophic factor (CNTF) TTGEM5Q CNTF_HUMAN Modulator [2]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Ciliary neurotrophic factor (CNTF) DTT CNTF 5.945 5.289 5.771 6.172
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

ICD Disease Classification 02 Neoplasm
Disease Class ICD-11: 2C82 Prostate cancer
The Studied Tissue Ovarian tissue
The Studied Disease Ovarian cancer [ICD-11:2C82]
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Ciliary neurotrophic factor (CNTF) DTT CNTF 2.98E-01 -0.29 -0.7
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 ClinicalTrials.gov (NCT01648452) CNTF Implants for CNGB3 Achromatopsia. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Neurotech.